Replies to post #6924 on Synaptogenix Inc (SNPX)

[runncoach]

They raised funds last time which caused the pullback. The sad thing is this is about the exact price of the stock when I first found it and its been de-risked so much since then. Added Perry to the board. Beginning the Fragile X study. Adding new indications such as PD and MS. We're still early in the game but the good news is we'll likely know drug effectiveness for our primary indication in roughly 9 months. If it doesn't pan out folks have gambled and lost on a 7 dollar stock. If it proves to be an effective treatment for a platform of CNS issues, its a 100 bagger. Pretty good risk/reward if you're not gambling house money. JMHO